World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
12618
World Ranking
3011
National Ranking
1198

Neil Parkin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Neil Parkin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 156 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Neil Parkin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Neil Parkin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 61 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Neil Parkin is affiliated with Data First Consulting in the United States and has contributed to research primarily in the fields of Medicine and Engineering. Their work is particularly focused within several subfields, including Infectious Diseases, Virology, Electrical and Electronic Engineering, Epidemiology, and Hepatology.

The research topics covered by Neil Parkin center around HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, as well as Hepatitis B and C virus studies. Additionally, they have engaged in areas related to Optical Network Technologies and Advanced Photonic Communication Systems.

Neil Parkin has published in various scientific venues. The most frequent publication venues include:

  • Viruses
  • UNC Libraries
  • Scientific Reports
  • Journal of Viral Hepatitis
  • Conference on Lasers and Electro-Optics

Recent research papers by Neil Parkin include:

  • Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations, 2020, Viruses
  • Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis, 2020, The Journal of Infectious Diseases
  • Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds, 2020, Viruses
  • Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing, 2020, Scientific Reports
  • Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping, 2020, Viruses

Neil Parkin has collaborated frequently with several researchers, including:

  • Robert W. Shafer
  • Hezhao Ji
  • Santiago Ávila-Ríos
  • Rami Kantor
  • Soo-Yon Rhee

Best Publications

  • A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

    Christos J. Petropoulos;Neil T. Parkin;Kay L. Limoli;Yolanda S. Lie

  • HIV-1 drug resistance in newly infected individuals.

    Daniel Boden;Arlene Hurley;Linqi Zhang;Yunzhen Cao

  • HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

    Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

    David R Bangsberg;Edward P Acosta;Reena Gupta;David Guzman

  • Hepatitis C virus drug resistance–associated substitutions: State of the art summary

    Erik Lontok;Patrick Harrington;Anita Howe;Tara Kieffer

  • The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

    Mina C. Hosseinipour;Joep J.G. van Oosterhout;Ralf Weigel;Sam Phiri

  • Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.

    Jeannette M. Whitcomb;Neil T. Parkin;Colombe Chappey;Nicholas S. Hellmann

  • Evidence for Positive Epistasis in HIV-1

    Sebastian Bonhoeffer;Colombe Chappey;Neil T. Parkin;Jeanette M. Whitcomb

  • Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

    Susan J. Little;Simon D. W. Frost;Joseph K. Wong;Davey M. Smith

  • Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

    Evguenia S. Svarovskaia;Hadas Dvory-Sobol;Neil Parkin;Christy Hebner

  • Novel Four-Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor-Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic Outcome

    Steven G. Deeks;Nicholas S. Hellmann;Robert M. Grant;Neil T. Parkin

  • An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA

    Mario Chamorro;Neil Parkin;Harold E. Varmus

  • Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product

    Sophie Roy;Michael G. Katze;Neil T. Parkin;Isaac Edery

  • Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

    Michael F. Maguire;Rosario Guinea;Philip Griffin;Sarah Macmanus

  • Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

    N T Parkin;E A Cohen;A Darveau;C Rosen

  • Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

    Wei Huang;Susan H. Eshleman;Jonathan Toma;Signe Fransen

  • Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.

    Martin Markowitz;Hiroshi Mohri;Saurabh Mehandru;Anita Shet

  • Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo.

    N T Parkin;M Chamorro;H E Varmus

  • Identification of I50L as the Signature Atazanavir (ATV)-Resistance Mutation in Treatment-Naive HIV-1-Infected Patients Receiving ATV-Containing Regimens

    Richard Colonno;Ronald Rose;Colin McLaren;Alexandra Thiry

Frequent Co-Authors

Christos J. Petropoulos
Christos J. Petropoulos LabCorp (United States)
Silvia Bertagnolio
Silvia Bertagnolio World Health Organization
Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Roger Paredes
Roger Paredes University of Vic - Central University of Catalonia
J. Brooks Jackson
J. Brooks Jackson University of Iowa Hospitals and Clinics
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Robert W. Shafer
Robert W. Shafer Stanford University
Soo-Yon Rhee
Soo-Yon Rhee Stanford University
Jonathan M. Schapiro
Jonathan M. Schapiro Sheba Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to various related fields and career paths, many of which offer flexible online degree options. For those interested in healthcare, several medical degrees online provide valuable credentials without the need to attend traditional campuses.

Public health is another key area linked to microbiology. Accredited programs offering an accredited online mph programs easy to get into allow students to gain important knowledge to tackle health issues from a broader perspective.

Careers in childhood development and support also intersect with microbiology, especially within healthcare settings. Understanding the role of a child life specialists salary can help prospective students evaluate this rewarding pathway, which often requires specialized certification.

For individuals with unique backgrounds, such as a criminal record, it’s encouraging to know that education remains accessible. Finding what is the best degree for a convicted felon can guide learners toward degrees that enhance employment prospects while accommodating their circumstances.

Best Scientists Citing Neil Parkin

Trending Scientists

Recently Published Articles